Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury
2007

TGF-β1 Overexpression and Pulmonary Fibrosis in Mice

Sample size: 48 publication 10 minutes Evidence: moderate

Author Information

Author(s): Haider Yussef, Malizia Andrea P, Keating Dominic T, Birch Mary, Tomlinson Annette, Martin Gail, Ferguson Mark WJ, Doran Peter P, Egan Jim J

Primary Institution: University of Manchester

Hypothesis

Does overexpression of TGF-β1 in mice lead to pulmonary fibrosis following bleomycin injury?

Conclusion

The study shows that TGF-β1 overexpression in mice does not cause lung fibrosis by itself but exacerbates fibrosis when combined with bleomycin injury.

Supporting Evidence

  • TGF-β1 overexpression led to severe liver fibrosis but not lung fibrosis in transgenic mice.
  • Bleomycin exposure resulted in more severe lung injury in TGF-β1 transgenic mice compared to wild type.
  • Gene expression analysis revealed distinct patterns associated with lung injury and fibrosis.

Takeaway

Mice with extra TGF-β1 didn't get lung scarring on their own, but when they got a medicine that hurts the lungs, they got really bad scarring.

Methodology

Transgenic mice overexpressing TGF-β1 were treated with bleomycin, and lung fibrosis was assessed histologically and biochemically.

Potential Biases

Potential bias in interpreting results due to reliance on a single animal model.

Limitations

The study primarily uses a mouse model, which may not fully replicate human disease mechanisms.

Participant Demographics

Transgenic mice (line 18 and line 25) were used in the study.

Statistical Information

P-Value

0.16 for total TGF-β1 levels; p<0.01 for active TGF-β1 levels.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-9255-4-18

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication